share_log

BRIEF-Sarepta Therapeutics Posts Q4 Loss Per Share Of $2.40

路透社 ·  Mar 2, 2021 07:51
March 1 (Reuters) - Sarepta Therapeutics Inc :
   * SAREPTA THERAPEUTICS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS AND RECENT CORPORATE DEVELOPMENTS
   * Q4 NON-GAAP LOSS PER SHARE $1.84
   * Q4 EARNINGS PER SHARE ESTIMATE $-1.87 -- REFINITIV IBES DATA
   * NET PRODUCT SALES FOR Q4 OF $122.6 MILLION
   * QTRLY TOTAL REVENUES $145.1 MILLION VERSUS $100.1 MILLION
   * QTRLY LOSS PER SHARE $2.40

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment